Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BBOT
FATE
Add up to 3 more stocks
BBOT
BridgeBio Oncology Therapeutics Inc.
+1.25%
$3.65+0.04Delayed quote: Oct 6, 2026, 11:00 AM EDT
Market Cap
$291.99M
52W Range
$3.58 - $14.87
FATE
Fate Therapeutics, Inc.
-2.88%
$2.36-0.07Delayed quote: Oct 6, 2026, 11:00 AM EDT
Market Cap
$275.08M
52W Range
$0.95 - $3.23
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.90 | 1.79 |
| P/S Ratio | N/A | 42.38 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | -94.1% |
| Operating Margin | 0.0% | -2222.4% |
| Net Margin | 0.0% | -1941.1% |
| ROE | -56.4% | -82.1% |
| ROA | -48.3% | -48.4% |
| ROIC | -61.1% | -58.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.69 | 4.85 |
| Quick Ratio | 4.69 | 4.85 |
| Debt/Equity | 0.01 | 0.49 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.